CB2 cannabinoid receptor agonist selectively inhibits the mechanosensitivity of mucosal afferents in the guinea pig bladder

Stewart Christie, Vladimir Zagorodnyuk

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)


Bladder afferents play a pivotal role in bladder function such as urine storage and micturition as well as conscious sensations such as urgency and pain. Endocannabinoids are ligands of cannabinoid 1 and 2 (CB1 and CB2) receptors but can influence the activity of a variety of G protein-coupled receptors as well as ligand-gated and voltage-gated channels. It is still not known which classes of bladder afferents are influenced by CB1 and CB2 receptor agonists. This study aimed to determine the role of CB2 receptors in two major classes of afferents in the guinea pig bladder: mucosal and muscular-mucosal. The mechanosensitivity of these two classes was determined by an ex vivo extracellular electrophysiological recording technique. A stable analog of endocannabinoid anandamide, methanandamide (mAEA), potentiated the mechanosensitivity of mucosal bladder afferents in response to stroking. In the presence of a transient receptor potential vanilloid 1 antagonist (capsazepine), the effect of mAEA switched from excitatory to inhibitory. A selective CB2 receptor agonist, 4-quinolone-3-carboxyamide (4Q3C), significantly inhibited the mechanosensitivity of mucosal bladder afferents to stroking. In the presence of a CB2 receptor antagonist, the inhibitory effect of 4Q3C was lost. mAEA and 4Q3C did not affect responses to stretch and/or mucosal stroking of muscular-mucosal afferents. Our findings revealed that agonists of CB2 receptors selectively inhibited the mechanosensitivity of capsaicin-sensitive mucosal bladder afferents but not muscular-mucosal afferents. This may have important implications for understanding of the role of endocannabinoids in modulating bladder function and sensation in health and diseases.NEW & NOTEWORTHY This article describes, for the first time, to our knowledge, the direct inhibitory effect of cannabinoid 2 receptor agonists on guinea pig mucosal bladder afferents. The cannabinoid 2 receptor is involved in pain and inflammation, suggesting that this may be a viable target for treatment of bladder disorders such as cystitis.

Original languageEnglish
Pages (from-to)F859-F865
JournalAmerican journal of physiology. Renal physiology
Issue number5
Publication statusPublished or Issued - 1 May 2021
Externally publishedYes


  • Animals
  • Arachidonic Acids/pharmacology
  • Camphanes/pharmacology
  • Cannabinoid Receptor Agonists/pharmacology
  • Cannabinoid Receptor Antagonists/pharmacology
  • Capsaicin/analogs & derivatives
  • Endocannabinoids/metabolism
  • Female
  • Guinea Pigs
  • Ligands
  • Mechanotransduction, Cellular/drug effects
  • Mucous Membrane/innervation
  • Muscle, Smooth/innervation
  • Neurons, Afferent/drug effects
  • Pyrazoles/pharmacology
  • Receptor, Cannabinoid, CB2/agonists
  • TRPV Cation Channels/antagonists & inhibitors
  • Urinary Bladder/innervation

Cite this